Immediate Impact
1 from Science/Nature 71 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of J. Peter being referenced
Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus
2011
Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| J. Peter | 681 | 407 | 625 | 12 | 923 | |
| Ann Michelini | 708 | 384 | 493 | 15 | 983 | |
| Riley Fadden | 696 | 186 | 231 | 19 | 890 | |
| R H Reznek | 545 | 105 | 433 | 23 | 1.1k | |
| Raphael Levey | 202 | 215 | 135 | 15 | 899 | |
| Valentine Jehl | 789 | 522 | 720 | 23 | 1.1k | |
| Sui Zee | 917 | 191 | 518 | 14 | 1.2k | |
| P SWALSKY | 713 | 59 | 186 | 13 | 914 | |
| Laura Tang | 481 | 347 | 507 | 15 | 768 | |
| Alejandra Flores-Chávez | 703 | 63 | 107 | 14 | 1.2k | |
| A. Loverre | 465 | 44 | 194 | 7 | 885 |
All Works
Loading papers...